Galapagos looking for acquisitions after drug deal
AMSTERDAM (Reuters) - Galapagos is looking for acquisitions after it received $150 million euros in upfront payments from a deal with U.S. Abbott Laboratories (ABT.N) for its leading drug.
"It would have to fit into what we are already doing and make financial sense," Chief Executive Onno van de Stolpe told a news conference on Wednesday.
(Reporting by Anthony Deutsch, writing by Ben Deighton)
- U.S. small businesses borrowed more money in January than they did a year earlier, signaling continued growth in the economy despite a spate of cold weather that has been blamed for weakness in many other indicators of activity.
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.